Mark Simon

Insider Reports History

Entity
Individual
Location
C/O Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury, NJ
Signature
/s/ Michael Gerard, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Simon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cabaletta Bio, Inc. Director Stock Option (Right to Buy) 22K Jun 3, 2024 Direct

Insider Reports Filed by Mark Simon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CABA Cabaletta Bio, Inc. Jun 3, 2024 1 $0 4 Jun 4, 2024 Director
CABA Cabaletta Bio, Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
CABA Cabaletta Bio, Inc. Oct 18, 2022 2 $122K 4 Oct 18, 2022 Director
CABA Cabaletta Bio, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
CABA Cabaletta Bio, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director